Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Identification of a Danger-Associated Peptide From Apolipoprotein B100 (ApoBDS-1) That Triggers Innate Proatherogenic Responses

  • Daniel F. J. Ketelhuth
  • Francisco J. O. Rios
  • Yajuan Wang
  • Huiqing Liu
  • Maria E. Johansson
  • Gunilla Nordin Fredrikson
  • Ulf Hedin
  • Magnus Gidlund
  • Jan Nilsson
  • Goran K. Hansson
  • Zhong-qun Yan
Publishing year: 2011
Language: English
Pages: 2433-2433
Publication/Series: Circulation
Volume: 124
Issue: 22
Document type: Journal article
Publisher: Lippincott Williams and Wilkins

Abstract english

Background-Subendothelial deposited low-density lipoprotein particles are a known inflammatory factor in atherosclerosis. However, the causal components derived from low-density lipoprotein are still poorly defined. Apolipoprotein B100 (ApoB100) is the unexchangeable protein component of low-density lipoprotein, and the progression of atherosclerosis is associated with immune responses to ApoB100-derived peptides. In this study, we analyzed the proinflammatory activity of ApoB100 peptides in atherosclerosis. Methods and Results-By screening a peptide library of ApoB100, we identified a distinct native peptide referred to as ApoB100 danger-associated signal 1 (ApoBDS-1), which shows sequence-specific bioactivity in stimulation of interleukin-8, CCL2, and interleukin-6. ApoBDS-1 activates mitogen-activated protein kinase and calcium signaling, thereby effecting the expression of interleukin-8 in innate immune cells. Ex vivo stimulation of carotid plaques with ApoBDS-1 enhances interleukin-8 and prostaglandin E(2) release. Furthermore, we demonstrated that ApoBDS-1-positive peptide fragments are present in atherosclerotic lesions using immunoassays and that low-molecular-weight fractions isolated from plaque show ApoBDS-1 activity inducing interleukin-8 production. Conclusions-Our data show that ApoBDS-1 is a previously unrecognized peptide with robust proinflammatory activity, contributing to the disease-promoting effects of low-density lipoprotein in the pathogenesis of atherosclerosis. (Circulation. 2011; 124: 2433-2443.)


  • Cardiac and Cardiovascular Systems
  • apolipoprotein B100
  • atherosclerosis
  • innate immunity
  • macrophage
  • oxidized LDL


  • Cardiovascular Research - Immunity and Atherosclerosis
  • ISSN: 1524-4539
E-mail: jan [dot] nilsson [at] med [dot] lu [dot] se

Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00